Skip to main page content

Sanjay Asrani MD

Glaucoma
Participates in 9 items

Dr. Asrani is Professor of Ophthalmology at Duke University and Director of the Duke Eye Center of Cary and the Duke Glaucoma OCT Reading Center.  

Dr. Asrani is the recipient of numerous awards, including the Career Development Award from Research to Prevent Blindness, Inc, the Helen Keller Award from the American Glaucoma Society, the Senior Achievement and the Secretariat Awards from the American Academy of Ophthalmology.  

Dr. Asrani has over 100 peer reviewed publications and serves on the editorial board of Journal of Glaucoma, Advances in Therapy, and Ophthalmology and Therapeutics 

He has developed a new glaucoma implant and a new software for OCT for glaucoma diagnosis 

Financial disclosure: Dr. Asrani has/had an affiliation (financial or otherwise) with a commercial organization:

  • Ripple Therapeutics - Consultant
  • ONL Therapeutics - Consultant
  • NICOX Inc - Advisory Board
  • ICARE Inc - Speakers Bureaus
  • Heidelberg Engineering - Speakers Bureaus

Sessions in which Sanjay Asrani MD participates

Saturday 21 June, 2025

Time Zone: (GMT-05:00) Eastern Time (US & Canada)
2:00 PM
2:00 PM - 3:30 PM | 1 hour 30 minutes
Glaucoma

Learning ObjectivesAt the end of this session, participants will be able to:Develop the ability to critically interpret and integrate findings from optical coherence tomography (OCT) and visual field testing to accurately diagnose and monitor glaucomaRecognize common pitfalls and artifacts in OCT and visual field analyses and...

2:20 PM
4:15 PM
4:15 PM - 5:45 PM | 1 hour 30 minutes
Glaucoma

Learning ObjectivesAt the end of this session, participants will be able to:Discuss perioperative issues and care in glaucoma surgical management  Describe the various gl...

5:40 PM

Sunday 22 June, 2025

Time Zone: (GMT-05:00) Eastern Time (US & Canada)
8:30 AM
8:30 AM - 10:30 AM | 2 hours
Current Concepts

Learning ObjectivesAt the end of this session, participants will be able to:Describe recruitment challenges and strategies for enrolling underserved populations in clinical trials.CanMEDS: Medical Expert, Scholar

9:30 AM